Frederique Ph.D. Menzaghi - 01 Mar 2023 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CARA	Stock Option (Right to Buy)	Award	$0	+81,000		$0.000000	81,000	01 Mar 2023	Common Stock	81,000	$10.06	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on April 1, 2023, in each case subject to the Reporting Person's continued service as of each such date.